BS

Bhawana Swapnil Gautam

Active Director Designated Partner DIN 07678026
DIN 07678026 First appointment Dec 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhawana Swapnil Gautam

Data last updated:

Bhawana Swapnil Gautam is a Designated Partner at Narayani Hospital Llp (since 2016). The company operates in Healthcare.

DIN 07678026
Primary Designation Designated Partner
Industry Healthcare
First Appointment 30 Dec 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner30 Dec 20162016Active

Board colleagues of Bhawana Swapnil Gautam

NameDINCompanyDesignation
Snehil Gautam07678206Narayani Hospital LlpDesignated Partner
Swapnil Gautam07678087Narayani Hospital LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Narayani Hospital Llp
Premium access

Shareholding and investment profile for Bhawana Swapnil Gautam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhawana Swapnil Gautam

Bhawana Swapnil Gautam currently holds 1 directorship: Narayani Hospital Llp (Designated Partner, since 30 Dec 2016).

Bhawana Swapnil Gautam was first appointed on 30 Dec 2016 as Designated Partner at Narayani Hospital Llp.

The current boards of Bhawana Swapnil Gautam's companies include Snehil Gautam (Narayani Hospital Llp), Swapnil Gautam (Narayani Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available